Stockscreener 앱 받기
2.71
4.23%
0.11
시간 외 거래:
2.66
-0.05
-1.85%
전일 마감가:
$2.60
열려 있는:
$2.63
하루 거래량:
789.73K
Relative Volume:
2.67
시가총액:
$104.72M
수익:
$2.76M
순이익/손실:
$-49.12M
주가수익비율:
-1.8067
EPS:
-1.5
순현금흐름:
$-46.21M
1주 성능:
+11.07%
1개월 성능:
-7.51%
6개월 성능:
-50.64%
1년 성능:
-59.06%
1일 변동 폭
$2.62
$2.78
1주일 범위
$2.52
$2.78
52주 변동 폭
$2.37
$7.04
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
명칭
Orchestra Biomed Holdings Inc
전화
646-343-9298
주소
150 UNION SQUARE DRIVE, NEW HOPE
OBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
2.71 | 142.44M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-20 | 개시 | BTIG Research | Buy |
| 2025-01-02 | 개시 | Barclays | Overweight |
| 2024-08-22 | 개시 | H.C. Wainwright | Buy |
| 2024-07-25 | 개시 | B. Riley Securities | Buy |
| 2024-01-19 | 개시 | Jefferies | Buy |
| 2023-02-24 | 개시 | Piper Sandler | Overweight |
| 2023-02-07 | 개시 | Chardan Capital Markets | Buy |
모두보기
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
Long term hold vs stop loss in Orchestra BioMed Holdings Inc.Free Smart Trade Plans With Risk Protection - Newser
Advanced analytics toolkit walkthrough for Orchestra BioMed Holdings Inc.Swing Entry Risk Mitigation with Chart Analysis - Newser
Orchestra BioMed Holdings Inc. stock trend outlook and recovery pathFree Beginner Friendly Stock Selection Guide - Newser
Will Orchestra BioMed Holdings Inc. continue its uptrendFree Capital Preserving Trade Plan Templates - Newser
Reversal indicators forming on Orchestra BioMed Holdings Inc. stockWealth Accumulation Outlook for Safe Investors - Newser
Real time pattern detection on Orchestra BioMed Holdings Inc. stockFree Weekly Top Gainers Forecast Watchlist - Newser
SEC Filings Archive 2025-08-08Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Regression analysis insights on Orchestra BioMed Holdings Inc. performanceHigh Probability Trade Outcome Prediction - Newser
What MACD and RSI say about Orchestra BioMed Holdings Inc.Value Investing Summary and Earnings Outlook - Newser
Orchestra BioMed stock rises on trial update (OBIO:NASDAQ) - Seeking Alpha
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT - GlobeNewswire
FDA Approves 24x Patient Expansion for Orchestra BioMed Hypertension Trial | OBIO Stock News - Stock Titan
Should you wait for a breakout in Orchestra BioMed Holdings Inc.Strategy Playbook for Risk Controlled Trades - Newser
Orchestra Biomed Holdings, Inc. shares fall 2.31% after-hours following a strategic transaction and equity offering. - AInvest
Orchestra BioMed: Chardan Capital Keeps Buy Rating, PT Raised to $20. - AInvest
Major Investment Alert: Perceptive Advisors Boosts Stake in Orchestra BioMed! - TipRanks
Orchestra BioMed Secures $111 Million - citybiz
Perceptive Advisors buys 700k Orchestra BioMed shares at $2.75 per share. - AInvest
Medtronic (MDT) Invests in Orchestra BioMed's Strategic Expansion - GuruFocus
Orchestra BioMed Raises $111.2M for AVIM Therapy Advancement - AInvest
Orchestra BioMed Secures Over $111 Million in Proceeds and - GlobeNewswire
Orchestra BioMed Secures Massive $111M Funding: Medtronic, Ligand Back Late-Stage Clinical Trials - Stock Titan
Orchestra BioMed’s CEO Makes Bold Stock Purchase! - TipRanks
Orchestra BioMed director Hochman buys $55,000 in OBIO stock By Investing.com - Investing.com Canada
Orchestra BioMed director Hochman buys $55,000 in OBIO stock - Investing.com
Orchestra BioMed Director Hochman Buys 20,000 Shares at $2.75 Per Share - AInvest
Orchestra BioMed Holdings Closes $40M Public Offering - TipRanks
How does Orchestra BioMed Holdings Inc. generate profit in a changing economyAchieve rapid portfolio growth with smart picks - Jammu Links News
Why is Orchestra BioMed Holdings Inc. stock attracting strong analyst attentionCapitalize on emerging market opportunities - Jammu Links News
What is the dividend policy of Orchestra BioMed Holdings Inc. stockFree Consultation - Jammu Links News
What are analysts’ price targets for Orchestra BioMed Holdings Inc. in the next 12 monthsDiscover hidden gems in the stock market - Jammu Links News
Should I hold or sell Orchestra BioMed Holdings Inc. stock in 2025Maximize your gains with professional insights - Jammu Links News
What institutional investors are buying Orchestra BioMed Holdings Inc. stockOver 200% growth - Jammu Links News
What makes Orchestra BioMed Holdings Inc. stock price move sharplyUnlock powerful portfolio optimization tools - Jammu Links News
Is Orchestra BioMed Holdings Inc. a good long term investmentRapid market gains - Jammu Links News
Does Orchestra BioMed Holdings Inc. stock perform well during market downturnsRapid growth opportunities - Jammu Links News
How does Orchestra BioMed Holdings Inc. compare to its industry peersMaximize gains with expert analysis - Jammu Links News
What are Orchestra BioMed Holdings Inc. company’s key revenue driversMarket-crushing stock picks - Jammu Links News
What analysts say about Orchestra BioMed Holdings Inc. stockTriple-digit return opportunities - Jammu Links News
Orchestra BioMed announces pricing of $40 million public offering - MSN
Can Orchestra BioMed Holdings Inc. hit a new high this monthShort-Term Growth Watch with Signal Prediction - Newser
How to integrate Orchestra BioMed Holdings Inc. into portfolio analysis toolsOversold Stock Bounce Playbook Generator - Newser
Will Orchestra BioMed Holdings Inc. benefit from macro trendsSummary of Reliable Long-Term Trade Models - Newser
How Orchestra BioMed Holdings Inc. stock performs during market volatilityFree Stock Portfolio Allocation Guidance - Newser
Is Orchestra BioMed Holdings Inc. still worth holding after the dipEntry Zone Watchlist With Momentum Focus - Newser
Trendlines Suggest Orchestra BioMed Holdings Inc. May Bottom Out SoonMarket Momentum and Signal Alerts Suggest Reversal - metal.it
Applying Wyckoff theory to Orchestra BioMed Holdings Inc. stockFree Investment Playbook for Growing Markets - Newser
RSI Reset May Fuel Rebound in Orchestra BioMed Holdings Inc.Long Hold Safe Return Strategy Reviewed - metal.it
Latham Advises on Orchestra BioMed’s US$40 Million Public Offering - Latham & Watkins LLP
Orchestra BioMed Prices $40 Million Public Offering - citybiz
Orchestra BioMed Announces Pricing of $40 Million Public Offering - The Manila Times
Orchestra Biomed Holdings Inc (OBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):